Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons
Top Cited Papers
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 55 (3) , 509-550
- https://doi.org/10.1124/pr.55.3.2
Abstract
The molecular basis for the known intramembrane receptor/receptor interactions among G protein-coupled receptors was postulated to be heteromerization based on receptor subtype-specific interactions between different types of receptor homomers. The discovery of GABAB heterodimers started this field rapidly followed by the discovery of heteromerization among isoreceptors of several G protein-coupled receptors such as δ/κ opioid receptors. Heteromerization was also discovered among distinct types of G protein-coupled receptors with the initial demonstration of somatostatin SSTR5/dopamine D2 and adenosine A1/dopamine D1 heteromeric receptor complexes. The functional meaning of these heteromeric complexes is to achieve direct or indirect (via adapter proteins) intramembrane receptor/receptor interactions in the complex. G protein-coupled receptors also form heteromeric complexes involving direct interactions with ion channel receptors, the best example being the GABAA/dopamine D5 receptor heteromerization, as well as with receptor tyrosine kinases and with receptor activity modulating proteins. As an example, adenosine, dopamine, and glutamate metabotropic receptor/receptor interactions in the striatopallidal GABA neurons are discussed as well as their relevance for Parkinson's disease, schizophrenia, and drug dependence. The heterodimer is only one type of heteromeric complex, and the evidence is equally compatible with the existence of higher order heteromeric complexes, where also adapter proteins such as homer proteins and scaffolding proteins can exist. These complexes may assist in the process of linking G protein-coupled receptors and ion channel receptors together in a receptor mosaic that may have special integrative value and may constitute the molecular basis for some forms of learning and memory.This publication has 410 references indexed in Scilit:
- Molecular tinkering of G protein-coupled receptors: an evolutionary successThe EMBO Journal, 1999
- The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31, Pro34]neuropeptide Y-induced modulation of α2-adrenoceptors in the nucleus tractus solitarii of the ratNeuroReport, 1996
- Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sitesNeuroscience Letters, 1996
- Stimulation of adenosine A2 receptors induces catalepsyNeuroscience Letters, 1991
- On the Role of Neuropeptide Y in Information Handling in the Central Nervous System in Normal and Physiopathological States.Annals of the New York Academy of Sciences, 1990
- Angiotensin II reduces the affinity of [3H]para‐aminoclonidine binding sites in membrane preparations from the rat dorsomedial medulla oblongataActa Physiologica Scandinavica, 1988
- Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortexNeuroscience Letters, 1988
- Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the ratNeuroscience Letters, 1983
- The size of the mammalian lung β2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatographyBiochemical and Biophysical Research Communications, 1982
- β-Adrenergic receptors: Evidence for negative cooperativityBiochemical and Biophysical Research Communications, 1975